Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank44
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P44
Within normal range
Streak
2 yr
Consecutive declineDecelerating
Average
4.71%
Historical baseline
PeriodValue
20250.00%
202492.94%
2023130.99%
2022103.89%
2021-7.23%
202015.32%
2019-87.22%
2018-71.62%
2017-129.94%
20160.00%